申请人:Research Corporation Technologies, Inc.
公开号:US05246955A1
公开(公告)日:1993-09-21
New cytotoxic quionones, designated amamitosenes and iminoazamitosenes are found to have significant activity against ovarian tumors, colon cancer, myecloma and the like neoplastic diseases. Pharmaceutical preparations and therapeutic regimens utilizing azamitosenes and iminoazamitosenes and their pharmaceutically active derivatives are disclosed.
新的细胞毒性喹诺酮,被命名为amamitosenes和iminoazamitosenes,发现对卵巢肿瘤、结肠癌、骨髓瘤等肿瘤性疾病具有显著的活性。公开了利用azamitosenes和iminoazamitosenes及其药物活性衍生物的制药制剂和治疗方案。